Logo - springer
Slogan - springer

| CNS Drugs – incl. option to publish open access (Editorial Board)

CNS Drugs

CNS Drugs

Editors: K. Palmer; S. Pochon

ISSN: 1172-7047 (print version)
ISSN: 1179-1934 (electronic version)

Journal no. 40263

Section Editors:

Martin Chopra

Alison Fitches

Dene Peters

Amitabh Prakash

Editorial Board:

D.S. Baldwin, University of Southampton, Southampton, England

T.R.E. Barnes, Imperial College London, London, England

M. Bialer, The Hebrew University of Jerusalem, Jerusalem, Israel

J. Biller, Loyola University Chicago, Maywood, IL, USA

H. Brodaty, Prince of Wales Hospital, Randwick, NSW, Australia

M.J. Brodie, West Glasgow Ambulatory Care Hospital, Glasgow, Scotland

M.J. Carpenter, Medical University of South Carolina, Charleston, SC, USA

M.C. Chamberlain, University of Washington, Seattle, WA, USA

D.R. Coghill, University of Melbourne, Melbourne, VIC, Australia

S. Cortese, University of Southampton, Southampton, England

M.J. Eadie, University of Queensland, Brisbane, QLD, Australia

M.R. Farlow, Indiana University School of Medicine, Indianapolis, IN, USA

G.A. Fava, University of Bologna, Bologna, Italy

W.W. Fleischhacker, Medical University Innsbruck, Innsbruck, Austria

S.H. Fox, University Health Network, Toronto, ON, Canada

G.T. Grossberg, St Louis University School of Medicine, St. Louis, MO, USA  

C. Guilleminault, Stanford Health Services, Stanford, CA, USA

D. Gurwitz, Tel-Aviv University, Tel Aviv, Israel

M. Hahn, Vitos Klinik, Eltville, Germany

G. Hajak, University of Regensburg, Regensburg, Germany

H-P. Hartung, Heinrich-Heine-University, Duesseldorf, Germany

M.W. Jann, University of North Texas, Fort Worth, TX, USA

D. Kemp, Case Western Reserve University, Cleveland, OH, USA

S.G. Kornstein, Virginia Commonwealth University, Richmond, VA, USA

P. Kwan, University of Melbourne, Royal Melbourne Hospital, Parkville, VIC, Australia

R.W. Lam, University of British Columbia, Vancouver, BC, Canada

L. Leggio, NIAAA and NIDA, NIH, Bethesda, MD, USA

B.E. Leonard, National University of Ireland, Galway, Ireland

P. Mitchell, University of New South Wales, Randwick, NSW, Australia

E. Perucca, University of Pavia, Pavia, Italy

R.M. Post, George Washington University, Washington DC and Bipolar Collaborative Network, Washington DC, USA

A.M. Rapoport, University of California, Los Angeles, CA, USA

O. Rascol, University Hospital, Toulouse, France

D.A. Revicki, Edivera, Bethesda, MD, USA

K.L. Roos, Indiana University Hospital, Indianapolis, IN, USA

J.F. Rosenbaum, Massachusetts General Hospital, Boston, MA, USA

M.V. Rudorfer, National Institute of Mental Health, Bethesda, MD, USA

S.C. Schachter, Beth Israel Deaconess Medical Center, Boston, MA, USA

S.A. Schug, Royal Perth Hospital, Perth, WA, Australia

S.D. Silberstein, Thomas Jefferson University Hospital, Philadelphia, PA, USA

D. Taylor, Maudsley Hospital, London, England

C. Trenkwalder, Paracelsus-Elena Hospital, Kassel, Germany

E. Trinka, Paracelsus Medical University Salzburg, Salzburg, Austria

B. Vitiello, University of Turin, Turin, Italy

B. Weinstock-Guttman, State University of New York, Buffalo, NY, USA

J.W. Winkelman, Harvard Medical School, Boston, MA, USA

J. Zajecka, Rush University Medical Center, Chicago, IL, USA

For authors and editors

  • Journal Citation Reports®, Thomson Reuters
    2015 Impact Factor
  • 4.910
  • Aims and Scope

    Aims and Scope


    CNS Drugs promotes rational pharmacotherapy and effective patient management within the
    disciplines of clinical psychiatry and neurology by providing a regular programme of review articles covering important issues in the drug treatment of psychiatric and neurological disorders. The Journal includes:

    • Leading/current opinion articles providing an overview of contentious or emerging issues.
    • Definitive reviews on approaches to the management of neurological and psychiatric illnesses.
    • Therapy in Practice reviews providing practical recommendations for specific clinical situations.
    • Adis Drug Evaluations reviewing the properties and place in therapy of both newer and established drugs in neurology and psychiatry.
    • Original research articles will also be considered for publication.

    All manuscripts are subject to peer review by international experts. Letters to the Editor are welcomed and will be considered for publication.

  • Submit Online
  • Open Choice - Your Way to Open Access
  • Instructions for Authors

    Instructions for Authors


  • Important Information for Authors
  • Conflict of Interest form (doc, 84 kB)
  • Copyright Information

    Copyright Information


    Copyright Information

    For Authors

    Submission of a manuscript implies: that the work described has not been published before (except in form of an abstract or as part of a published lecture, review or thesis); that it is not under consideration for publication elsewhere; that its publication has been approved by all co-authors, if any, as well as – tacitly or explicitly – by the responsible authorities at the institution where the work was carried out.

    Author warrants (i) that he/she is the sole owner or has been authorized by any additional copyright owner to assign the right, (ii) that the article does not infringe any third party rights and no license from or payments to a third party is required to publish the article and (iii) that the article has not been previously published or licensed. The author signs for and accepts responsibility for releasing this material on behalf of any and all co-authors. Transfer of copyright to Springer (respective to owner if other than Springer) becomes effective if and when a Copyright Transfer Statement is signed or transferred electronically by the corresponding author. After submission of the Copyright Transfer Statement signed by the corresponding author, changes of authorship or in the order of the authors listed will not be accepted by Springer.

    The copyright to this article, including any graphic elements therein (e.g. illustrations, charts, moving images), is assigned for good and valuable consideration to Springer effective if and when the article is accepted for publication and to the extent assignable if assignability is restricted for by applicable law or regulations (e.g. for U.S. government or crown employees).

    The copyright assignment includes without limitation the exclusive, assignable and sublicensable right, unlimited in time and territory, to reproduce, publish, distribute, transmit, make available and store the article, including abstracts thereof, in all forms of media of expression now known or developed in the future, including pre- and reprints, translations, photographic reproductions and microform. Springer may use the article in whole or in part in electronic form, such as use in databases or data networks for display, print or download to stationary or portable devices. This includes interactive and multimedia use and the right to alter the article to the extent necessary for such use.

    Authors may self-archive the Author's accepted manuscript of their articles on their own websites. Authors may also deposit this version of the article in any repository, provided it is only made publicly available 12 months after official publication or later. He/she may not use the publisher's version (the final article), which is posted on SpringerLink and other Springer websites, for the purpose of self-archiving or deposit. Furthermore, the Author may only post his/her version provided acknowledgement is given to the original source of publication and a link is inserted to the published article on Springer's website. The link must be accompanied by the following text: "The final publication is available at link.springer.com".

    Prior versions of the article published on non-commercial pre-print servers like arXiv.org can remain on these servers and/or can be updated with Author's accepted version. The final published version (in pdf or html/xml format) cannot be used for this purpose. Acknowledgement needs to be given to the final publication and a link must be inserted to the published article on Springer's website, accompanied by the text "The final publication is available at link.springer.com". Author retains the right to use his/her article for his/her further scientific career by including the final published journal article in other publications such as dissertations and postdoctoral qualifications provided acknowledgement is given to the original source of publication.

    Author is requested to use the appropriate DOI for the article. Articles disseminated via link.springer.com are indexed, abstracted and referenced by many abstracting and information services, bibliographic networks, subscription agencies, library networks, and consortia.

    For Readers

    While the advice and information in this journal is believed to be true and accurate at the date of its publication, neither the authors, the editors, nor the publisher can accept any legal responsibility for any errors or omissions that may have been made. The publisher makes no warranty, express or implied, with respect to the material contained herein.

    All articles published in this journal are protected by copyright, which covers the exclusive rights to reproduce and distribute the article (e.g., as offprints), as well as all translation rights. No material published in this journal may be reproduced photographically or stored on microfilm, in electronic data bases, video disks, etc., without first obtaining written permission from the publisher (respective the copyright owner if other than Springer). The use of general descriptive names, trade names, trademarks, etc., in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.

    Springer has partnered with Copyright Clearance Center's RightsLink service to offer a variety of options for reusing Springer content. For permission to reuse our content please locate the material that you wish to use on link.springer.com or on springerimages.com and click on the permissions link or go to copyright.com, then enter the title of the publication that you wish to use. For assistance in placing a permission request, Copyright Clearance Center can be connected directly via phone: +1-855-239-3415, fax: +1-978-646-8600, or e-mail: info@copyright.com.

    © Springer International Publishing Switzerland

Services for the Journal

Alerts for this journal


Get the table of contents of every new issue published in CNS Drugs.

Additional information